CORT

Corcept Therapeutics Inc

$114.95

3.96 (3.58%) Today

0.48 (0.42%) After-hours

— up— down

Compare CORT

Market Cap

$12.35B+59.5%

Revenue (TTM)

$758.63M+16.0%

Net Income (TTM)

$46.06M-62.5%

EPS (TTM)

0.43-62.5%

Shares Out

108.10M

P/E Ratio

218.62

Forward P/E

61.38

Open

$114.47

Previous Close

$110.51

Day Range

$110.11 – $114.90

52-Week Range

$28.66 – $122.21

Beta

0.40

Volume

727.89K

Avg Volume

1.14M

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About CORT

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.